+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Restex"

Restex - API Insight, 2022 - Product Thumbnail Image

Restex - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Restex- Drug Insight, 2019 - Product Thumbnail Image

Restex- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Restex market is a subset of the Central Nervous System (CNS) drugs market, which includes drugs used to treat neurological and psychiatric disorders. These drugs are used to treat a wide range of conditions, including Alzheimer's disease, Parkinson's disease, depression, anxiety, and schizophrenia. Restex drugs are used to treat conditions such as insomnia, narcolepsy, and sleep apnea. These drugs are typically prescribed to help patients achieve a better quality of sleep, as well as to reduce the risk of developing other medical conditions. The Restex market is highly competitive, with a number of major pharmaceutical companies competing for market share. Some of the leading companies in the market include Sanofi, Pfizer, GlaxoSmithKline, Merck, and Novartis. These companies are constantly developing new drugs and formulations to meet the needs of patients and healthcare providers. Show Less Read more